Panel Discussions

Friday, October 14th      8:00 am – 9:00 am

Options & Evidence: Novel Diagnostics

Sponsored by

Panelists:  Drs. Heather Wilson-Robles, Gerald Post, Esther Chon and Andi Flory

Moderator:  Dr. Timothy Fan

The potential and rational inclusion of targeted therapies for managing veterinary cancers requires an understanding of new sequencing technologies and biomarker discovery strategies. Currently, several screening tests have been developed for the potential detection of cancer within biologic fluids and could advance the practice of veterinary oncologic healthcare. This panel discussion will interrogate the potential value of personalized cancer diagnosis and therapy through a Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis, and will serve as a foundation to educate veterinary healthcare providers with a balanced knowledge base sufficient to guide and educate pet owners seeking to learn about targeted therapies.

 

Friday, October 14th     1:30 pm – 2:30 pm

Options & Evidence: Mast Cell Tumors

Sponsored by

Panelists:  Drs. Cheryl London and Craig Clifford

Moderator: Dr. Doug Thamm

This panel discussion will address current issues regarding the management of canine mast cell tumor, including diagnosis, treatment and prognosis. Topics to be discussed include the utility of sentinel lymph node mapping and histological assessment, the role for “prognostic panels” in providing prognostic information and directing therapy, the utility of postoperative tyrosine kinase inhibitor therapy, and the role of Stelfonta.